vs

Side-by-side financial comparison of ENANTA PHARMACEUTICALS INC (ENTA) and FREQUENCY ELECTRONICS INC (FEIM). Click either name above to swap in a different company.

ENANTA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($18.6M vs $17.1M, roughly 1.1× FREQUENCY ELECTRONICS INC). FREQUENCY ELECTRONICS INC runs the higher net margin — 10.5% vs -64.1%, a 74.6% gap on every dollar of revenue. On growth, ENANTA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.8% vs 8.3%). FREQUENCY ELECTRONICS INC produced more free cash flow last quarter ($-1.1M vs $-11.8M). Over the past eight quarters, FREQUENCY ELECTRONICS INC's revenue compounded faster (11.8% CAGR vs 4.5%).

Enanta Pharmaceuticals Inc is a clinical-stage biotechnology company that develops innovative antiviral therapies for infectious diseases including hepatitis B virus, respiratory syncytial virus (RSV), and SARS-CoV-2. It operates primarily in the U.S. and global markets, partnering with pharmaceutical firms to advance its small molecule drug candidate pipeline for patients with unmet medical needs.

Ultra Electronics Holdings is a British defence and security company. It was listed on the London Stock Exchange and was a constituent of the FTSE 250 Index until it was acquired by Cobham, which is itself owned by Advent International.

ENTA vs FEIM — Head-to-Head

Bigger by revenue
ENTA
ENTA
1.1× larger
ENTA
$18.6M
$17.1M
FEIM
Growing faster (revenue YoY)
ENTA
ENTA
+1.5% gap
ENTA
9.8%
8.3%
FEIM
Higher net margin
FEIM
FEIM
74.6% more per $
FEIM
10.5%
-64.1%
ENTA
More free cash flow
FEIM
FEIM
$10.7M more FCF
FEIM
$-1.1M
$-11.8M
ENTA
Faster 2-yr revenue CAGR
FEIM
FEIM
Annualised
FEIM
11.8%
4.5%
ENTA

Income Statement — Q1 FY2026 vs Q2 FY2026

Metric
ENTA
ENTA
FEIM
FEIM
Revenue
$18.6M
$17.1M
Net Profit
$-11.9M
$1.8M
Gross Margin
38.2%
Operating Margin
-60.5%
10.0%
Net Margin
-64.1%
10.5%
Revenue YoY
9.8%
8.3%
Net Profit YoY
46.4%
-32.1%
EPS (diluted)
$-0.42
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ENTA
ENTA
FEIM
FEIM
Q4 25
$18.6M
$17.1M
Q3 25
$15.1M
$13.8M
Q2 25
$18.3M
$20.0M
Q1 25
$14.9M
$18.9M
Q4 24
$17.0M
$15.8M
Q3 24
$14.6M
$15.1M
Q2 24
$18.0M
$15.6M
Q1 24
$17.1M
$13.7M
Net Profit
ENTA
ENTA
FEIM
FEIM
Q4 25
$-11.9M
$1.8M
Q3 25
$-18.7M
$634.0K
Q2 25
$-18.3M
$3.2M
Q1 25
$-22.6M
$15.4M
Q4 24
$-22.3M
$2.7M
Q3 24
$-28.8M
$2.4M
Q2 24
$-22.7M
$2.6M
Q1 24
$-31.2M
$130.0K
Gross Margin
ENTA
ENTA
FEIM
FEIM
Q4 25
38.2%
Q3 25
36.8%
Q2 25
37.5%
Q1 25
43.8%
Q4 24
48.2%
Q3 24
44.4%
Q2 24
40.3%
Q1 24
22.6%
Operating Margin
ENTA
ENTA
FEIM
FEIM
Q4 25
-60.5%
10.0%
Q3 25
-121.6%
2.6%
Q2 25
-103.2%
16.4%
Q1 25
-164.3%
18.3%
Q4 24
-138.8%
16.5%
Q3 24
-204.4%
15.7%
Q2 24
-134.6%
16.0%
Q1 24
-192.1%
-3.4%
Net Margin
ENTA
ENTA
FEIM
FEIM
Q4 25
-64.1%
10.5%
Q3 25
-123.6%
4.6%
Q2 25
-99.7%
16.0%
Q1 25
-151.7%
81.4%
Q4 24
-131.4%
16.8%
Q3 24
-197.3%
16.1%
Q2 24
-126.1%
16.9%
Q1 24
-182.7%
0.9%
EPS (diluted)
ENTA
ENTA
FEIM
FEIM
Q4 25
$-0.42
$0.18
Q3 25
$-0.88
$0.07
Q2 25
$-0.85
$0.33
Q1 25
$-1.06
$1.60
Q4 24
$-1.05
$0.28
Q3 24
$-1.36
$0.25
Q2 24
$-1.07
$0.28
Q1 24
$-1.47
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ENTA
ENTA
FEIM
FEIM
Cash + ST InvestmentsLiquidity on hand
$37.4M
$3.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$126.6M
$58.5M
Total Assets
$329.5M
$92.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ENTA
ENTA
FEIM
FEIM
Q4 25
$37.4M
$3.0M
Q3 25
$32.3M
$4.5M
Q2 25
$44.8M
$4.7M
Q1 25
$60.2M
$5.5M
Q4 24
$84.3M
$9.7M
Q3 24
$37.2M
$16.2M
Q2 24
$35.8M
$18.3M
Q1 24
$63.5M
$11.7M
Stockholders' Equity
ENTA
ENTA
FEIM
FEIM
Q4 25
$126.6M
$58.5M
Q3 25
$64.7M
$56.3M
Q2 25
$79.3M
$55.6M
Q1 25
$93.5M
$51.8M
Q4 24
$111.8M
$36.2M
Q3 24
$128.8M
$33.2M
Q2 24
$148.9M
$39.8M
Q1 24
$166.1M
$36.7M
Total Assets
ENTA
ENTA
FEIM
FEIM
Q4 25
$329.5M
$92.3M
Q3 25
$280.7M
$93.2M
Q2 25
$301.0M
$93.7M
Q1 25
$323.0M
$86.4M
Q4 24
$348.6M
$77.8M
Q3 24
$376.7M
$84.3M
Q2 24
$398.8M
$83.3M
Q1 24
$413.6M
$77.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ENTA
ENTA
FEIM
FEIM
Operating Cash FlowLast quarter
$-11.7M
$-523.0K
Free Cash FlowOCF − Capex
$-11.8M
$-1.1M
FCF MarginFCF / Revenue
-63.6%
-6.6%
Capex IntensityCapex / Revenue
0.8%
3.6%
Cash ConversionOCF / Net Profit
-0.29×
TTM Free Cash FlowTrailing 4 quarters
$-18.5M
$-5.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ENTA
ENTA
FEIM
FEIM
Q4 25
$-11.7M
$-523.0K
Q3 25
$-6.5M
$1.2M
Q2 25
$17.5M
$-155.0K
Q1 25
$-13.5M
$-3.6M
Q4 24
$-16.8M
$3.8M
Q3 24
$-10.4M
$-1.5M
Q2 24
$-14.8M
$7.5M
Q1 24
$-28.6M
$4.2M
Free Cash Flow
ENTA
ENTA
FEIM
FEIM
Q4 25
$-11.8M
$-1.1M
Q3 25
$-7.9M
$385.0K
Q2 25
$17.4M
$-786.0K
Q1 25
$-16.0M
$-4.0M
Q4 24
$-25.5M
$3.3M
Q3 24
$-19.4M
$-1.8M
Q2 24
$-21.3M
$6.7M
Q1 24
$-30.3M
$3.9M
FCF Margin
ENTA
ENTA
FEIM
FEIM
Q4 25
-63.6%
-6.6%
Q3 25
-52.5%
2.8%
Q2 25
94.7%
-3.9%
Q1 25
-107.4%
-20.9%
Q4 24
-150.6%
20.8%
Q3 24
-132.5%
-11.8%
Q2 24
-118.6%
42.8%
Q1 24
-177.5%
28.4%
Capex Intensity
ENTA
ENTA
FEIM
FEIM
Q4 25
0.8%
3.6%
Q3 25
9.6%
5.6%
Q2 25
0.8%
3.2%
Q1 25
17.0%
1.7%
Q4 24
51.6%
3.3%
Q3 24
61.3%
2.2%
Q2 24
36.4%
5.3%
Q1 24
9.8%
2.3%
Cash Conversion
ENTA
ENTA
FEIM
FEIM
Q4 25
-0.29×
Q3 25
1.83×
Q2 25
-0.05×
Q1 25
-0.24×
Q4 24
1.44×
Q3 24
-0.60×
Q2 24
2.85×
Q1 24
32.36×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ENTA
ENTA

Segment breakdown not available.

FEIM
FEIM

POC Revenue$14.8M86%
POT Revenue$2.3M13%

Related Comparisons